Entero Therapeutics, Inc. Made Headway
Mon, Aug 11, 2025 at 07:47 PM
Entero Therapeutics, Inc. (ENTO:NASDAQ) jumped higher at $0.61, a gain of 66.5%. On Mon, Aug 11, 2025, ENTO:NASDAQ touched a New 2-Week High of $0.61. The stock appeared on our News Catalysts scanner on Mon, Aug 11, 2025 at 10:24 AM in the 'PRIVATE PLACEMENT' category. From Mon, Jul 28, 2025, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Aug 11, 2025 at $0.78 with a volume of 299M+.
About Entero Therapeutics, Inc. (ENTO:NASDAQ)
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 138.1%
- Equillium, Inc. (EQ:NASDAQ), 78.88%
- Entero Therapeutics, Inc. (ENTO:NASDAQ), 66.46%
- Telos Corporation (TLS:NASDAQ), 62.61%
- International Money Express, Inc. (IMXI:NASDAQ), 60.56%
- CEA Industries Inc. (BNC:NASDAQ), 59.88%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 58.42%
- Kindly MD Inc. (NAKA:NASDAQ), 49.22%
- Aureus Greenway Holdings Inc. (AGH:NASDAQ), 46.97%
- Gamehaus Holdings Inc. (GMHS:NASDAQ), 46.73%